Prestige Consumer Healthcare Inc. (PBH) — SEC Filings
Prestige Consumer Healthcare Inc. (PBH) — 21 SEC filings. Latest: 10-Q (Nov 6, 2025). Includes 6 10-Q, 5 SC 13G/A, 4 8-K.
View Prestige Consumer Healthcare Inc. on SEC EDGAR
Overview
Prestige Consumer Healthcare Inc. (PBH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 6, 2025: Prestige Consumer Healthcare Inc. (PBH) reported a decline in net sales and net income for the three and six months ended September 30, 2025, compared to the prior year. For the three months, net sales decreased by 3.4% to $273,759 thousand from $283,548 thousand, and net income fell by 22.4% to $42
Sentiment Summary
Across 21 filings, the sentiment breakdown is: 2 bearish, 19 neutral. The dominant filing sentiment for Prestige Consumer Healthcare Inc. is neutral.
Filing Type Overview
Prestige Consumer Healthcare Inc. (PBH) has filed 6 10-Q, 2 DEF 14A, 2 10-K, 4 8-K, 5 SC 13G/A, 2 SC 13G with the SEC between Jan 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (21)
Risk Profile
Risk Assessment: Of PBH's 14 recent filings, 1 were flagged as high-risk, 4 as medium-risk, and 9 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $273,759,000 |
| Net Income | $42,211,000 |
| EPS | $0.86 |
| Cash Position | $119,106,000 |
| Total Assets | $3,442,280,000 |
| Total Debt | $993,146,000 |
Key Executives
- Dr. David R. Johnson
- Ms. Jennifer L. Smith
- Ms. Sarah M. Mook
- Mr. Steven J. Gremban
Industry Context
Prestige Consumer Healthcare operates in the consumer healthcare sector, which is generally stable but sensitive to economic conditions and consumer spending habits. The industry faces ongoing challenges from supply chain disruptions, rising input costs, and increasing competition. Companies often rely on strong brand recognition and effective marketing to maintain market share.
Top Tags
10-Q (4) · financials (3) · Consumer Healthcare (2) · OTC Products (2) · 10-K (2) · healthcare (2) · financial-reporting (2) · 8-K (2) · company-update (2) · governance (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Sales | $273.8M | Decreased 3.4% for the three months ended September 30, 2025, from $283.5M in 2024. |
| Net Income | $42.2M | Decreased 22.4% for the three months ended September 30, 2025, from $54.4M in 2024. |
| Diluted EPS | $0.86 | Decreased from $1.09 for the three months ended September 30, 2024, to $0.86 in 2025. |
| Provision for Income Taxes | $26.9M | Increased for the three months ended September 30, 2025, from $17.3M in 2024. |
| Treasury Share Repurchases | $115.0M | Increased for the six months ended September 30, 2025, from $43.9M in 2024. |
| Cash and Cash Equivalents | $119.1M | Increased from $97.9M at March 31, 2025, to September 30, 2025. |
| Product Revenue | $277.5M | Slight decrease from $280.0M in prior year, indicating stable demand. |
| North American OTC Healthcare Goodwill | $1.36B | Consistent goodwill reflects stable brand value and market position. |
| International OTC Healthcare Goodwill | $120.0M | Maintained goodwill indicates stable international brand strength. |
| Retained Earnings | $1.04B | Increased from $1.02B, showing profitability and financial health. |
| Additional Paid-In Capital | $1.10B | Increased from $1.09B, suggesting capital infusion or equity compensation. |
| Treasury Stock | $1.03B | Decreased from $1.04B, potentially indicating share repurchases. |
| Fiscal Year End | 2025-03-31 | End date of the reporting period |
| Filing Date | 2025-05-09 | Date the 10-K was submitted to the SEC |
| SEC File Number | 001-32433 | Identifies the company's filing history |
Forward-Looking Statements
- {"claim":"Prestige Consumer Healthcare Inc. stock may experience short-term selling pressure due to the reduction in institutional ownership.","entity":"Prestige Consumer Healthcare Inc.","targetDate":"3 months","confidence":"medium"}
- {"claim":"Other institutional investors might review their positions in Prestige Consumer Healthcare Inc. following this filing.","entity":"Institutional Investors","targetDate":"6 months","confidence":"medium"}
- {"claim":"Prestige Consumer Healthcare Inc. will continue to focus on managing its equity structure, potentially through share repurchases given the mention of 'Treasury Stock Common'.","entity":"Prestige Consumer Healthcare Inc.","targetDate":"2024-03-31","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Prestige Consumer Healthcare Inc. (PBH)?
Prestige Consumer Healthcare Inc. has 21 recent SEC filings from Jan 2024 to Nov 2025, including 6 10-Q, 5 SC 13G/A, 4 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PBH filings?
Across 21 filings, the sentiment breakdown is: 2 bearish, 19 neutral. The dominant sentiment is neutral.
Where can I find Prestige Consumer Healthcare Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Prestige Consumer Healthcare Inc. (PBH) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Prestige Consumer Healthcare Inc.?
Key financial highlights from Prestige Consumer Healthcare Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for PBH?
The investment thesis for PBH includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Prestige Consumer Healthcare Inc.?
Key executives identified across Prestige Consumer Healthcare Inc.'s filings include Dr. David R. Johnson, Ms. Jennifer L. Smith, Ms. Sarah M. Mook, Mr. Steven J. Gremban.
What are the main risk factors for Prestige Consumer Healthcare Inc. stock?
Of PBH's 14 assessed filings, 1 were flagged high-risk, 4 medium-risk, and 9 low-risk.
What are recent predictions and forward guidance from Prestige Consumer Healthcare Inc.?
Recent forward-looking statements from Prestige Consumer Healthcare Inc. include guidance on {"claim":"Prestige Consumer Healthcare Inc. stock may experience short-term selling pressure due to the reduction in ins and 2 other predictions.